Epidemiology of cytomegalovirus Infection among mothers and infants in Colombia.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
11 2021
Historique:
revised: 07 01 2021
received: 18 11 2020
accepted: 19 01 2021
pubmed: 22 1 2021
medline: 30 12 2021
entrez: 21 1 2021
Statut: ppublish

Résumé

We assessed maternal and infant cytomegalovirus (CMV) infection in Colombia. Maternal serum was tested for CMV immunoglobulin G antibodies at a median of 10 (interquartile range: 8-12) weeks gestation (n = 1501). CMV DNA polymerase chain reaction was performed on infant urine to diagnose congenital (≤21 days of life) and postnatal (>21 days) infection. Maternal CMV seroprevalence was 98.1% (95% confidence interval [CI]: 97.5%-98.8%). Congenital CMV prevalence was 8.4 (95% CI: 3.9%-18.3%; 6/711) per 1000 live births. Among 472 infants without confirmed congenital CMV infection subsequently tested at age 6 months, 258 (54.7%, 95% CI: 50.2%-59.1%) had postnatal infection.

Identifiants

pubmed: 33475162
doi: 10.1002/jmv.26815
pmc: PMC8292416
mid: NIHMS1682554
doi:

Substances chimiques

Antibodies, Viral 0
DNA, Viral 0
Immunoglobulin G 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

6393-6397

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Pediatrics. 2013 Jun;131(6):e1937-45
pubmed: 23713111
Am J Public Health. 2017 Apr;107(4):525-531
pubmed: 28207337
JAMA. 2010 Apr 14;303(14):1375-82
pubmed: 20388893
J Infect Dis. 2020 Mar 5;221(Suppl 1):S86-S93
pubmed: 32134475
Lancet Infect Dis. 2017 Jun;17(6):e177-e188
pubmed: 28291720
Int J Infect Dis. 2014 May;22:44-8
pubmed: 24631522
Epidemiol Health. 2020;42:e2020060
pubmed: 32882120
Clin Infect Dis. 2017 Aug 01;65(3):398-404
pubmed: 28419213
Pediatr Infect Dis J. 2018 Jul;37(7):627-631
pubmed: 29889809

Auteurs

Angelica Rico (A)

Instituto Nacional de Salud, Bogota, Colombia.

Sheila C Dollard (SC)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Diana Valencia (D)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sheryll Corchuelo (S)

Instituto Nacional de Salud, Bogota, Colombia.

Van T Tong (VT)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Katherine Laiton-Donato (K)

Instituto Nacional de Salud, Bogota, Colombia.

Minal M Amin (MM)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Monica Benavides (M)

Vysnova Partners, Inc., Landover, MD, USA.

Phili Wong (P)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Suzanne Newton (S)

Eagle Global Scientific, Atlanta, Georgia, USA.

Marcela Daza (M)

Vysnova Partners, Inc., Landover, MD, USA.

Jordan Cates (J)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Maritza Gonzalez (M)

Instituto Nacional de Salud, Bogota, Colombia.

Laura D Zambrano (LD)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Marcela M Mercado (MM)

Instituto Nacional de Salud, Bogota, Colombia.

Elizabeth C Ailes (EC)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Helena M Rodriguez (HM)

Instituto Nacional de Salud, Bogota, Colombia.

Suzanne M Gilboa (SM)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Jacqueline Acosta (J)

Vysnova Partners, Inc., Landover, MD, USA.

Jessica Ricaldi (J)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Dioselina Pelaez (D)

Instituto Nacional de Salud, Bogota, Colombia.

Margaret A Honein (MA)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Martha L Ospina (ML)

Instituto Nacional de Salud, Bogota, Colombia.

Tatiana M Lanzieri (TM)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH